Calamos Wealth Management LLC Has $9.45 Million Holdings in Danaher Co. (NYSE:DHR)

Calamos Wealth Management LLC grew its stake in Danaher Co. (NYSE:DHR - Free Report) by 2,875.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,829 shares of the conglomerate's stock after buying an additional 39,457 shares during the period. Calamos Wealth Management LLC's holdings in Danaher were worth $9,445,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. Moneta Group Investment Advisors LLC increased its stake in shares of Danaher by 96,490.5% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate's stock valued at $6,180,839,000 after buying an additional 23,262,904 shares during the period. Norges Bank acquired a new stake in Danaher during the fourth quarter worth approximately $2,057,164,000. Wellington Management Group LLP grew its stake in Danaher by 18.6% during the third quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate's stock worth $6,185,203,000 after purchasing an additional 3,905,449 shares during the period. Allen Investment Management LLC grew its stake in Danaher by 1,440.7% during the third quarter. Allen Investment Management LLC now owns 1,100,399 shares of the conglomerate's stock worth $273,009,000 after purchasing an additional 1,028,976 shares during the period. Finally, J.P. Morgan Private Wealth Advisors LLC acquired a new stake in Danaher during the third quarter worth approximately $178,850,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Barclays raised their target price on Danaher from $240.00 to $260.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 10th. Citigroup increased their price target on Danaher from $255.00 to $280.00 and gave the stock a "buy" rating in a report on Wednesday, January 31st. Royal Bank of Canada increased their price target on Danaher from $254.00 to $282.00 and gave the stock an "outperform" rating in a report on Wednesday, January 31st. StockNews.com lowered Danaher from a "buy" rating to a "hold" rating in a report on Wednesday, January 31st. Finally, HSBC upgraded Danaher from a "hold" rating to a "buy" rating and increased their price target for the stock from $250.00 to $280.00 in a report on Wednesday. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $268.27.

Insider Buying and Selling

In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the firm's stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the sale, the senior vice president now directly owns 38,102 shares of the company's stock, valued at $9,601,704. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the firm's stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the sale, the senior vice president now directly owns 38,102 shares of the company's stock, valued at $9,601,704. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Walter G. Lohr sold 3,289 shares of the firm's stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $251.15, for a total value of $826,032.35. Following the completion of the sale, the director now directly owns 14,129 shares of the company's stock, valued at $3,548,498.35. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,957 shares of company stock worth $8,265,802. 11.10% of the stock is owned by company insiders.

Danaher Stock Performance

Danaher stock traded down $0.85 during mid-day trading on Friday, reaching $235.51. 2,351,430 shares of the company's stock were exchanged, compared to its average volume of 2,437,629. The business's fifty day simple moving average is $248.94 and its 200 day simple moving average is $230.15. The firm has a market capitalization of $174.41 billion, a PE ratio of 36.86, a P/E/G ratio of 3.59 and a beta of 0.83. Danaher Co. has a one year low of $182.09 and a one year high of $259.00. The company has a quick ratio of 1.37, a current ratio of 1.68 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $1.91 by $0.18. The business had revenue of $6.41 billion for the quarter, compared to analyst estimates of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. Danaher's quarterly revenue was down 10.2% compared to the same quarter last year. During the same period last year, the company posted $2.87 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.62 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be issued a dividend of $0.27 per share. This is a positive change from Danaher's previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date is Wednesday, March 27th. Danaher's dividend payout ratio (DPR) is 16.90%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.